Regarding Type 1 lepra reaction (reversal reaction) in leprosy, all of the following statements are correct EXCEPT:

## Type 1 Lepra Reaction (Reversal Reaction) — Classification & Immunology ### Definition & Mechanism **Key Point:** Type 1 lepra reaction is a **Type IV delayed-type hypersensitivity** reaction to *Mycobacterium leprae* antigens. It occurs in patients with **borderline forms** of leprosy (BT, BB, BL) — NOT in pure tuberculoid (TT) or lepromatous (LL) forms. **High-Yield:** The key distinction is that Type 1 reactions occur in **unstable borderline forms** where cell-mediated immunity is present but not fully developed. TT (tuberculoid) and LL (lepromatous) are **stable polar forms** and do not undergo reversal reactions. ### Leprosy Classification & Reaction Susceptibility ```mermaid graph LR A["Leprosy Classification"] --> B["Tuberculoid Pole<br/>(TT)"] A --> C["Borderline Forms<br/>(BT, BB, BL)"] A --> D["Lepromatous Pole<br/>(LL)"] B -->|"Stable<br/>No Type 1"| E["TT: Stable"] C -->|"Unstable<br/>Type 1 possible"| F["BT, BB, BL:<br/>Reversal Reaction"] D -->|"Stable<br/>No Type 1"| G["LL: Stable"] C -->|"High bacillary load<br/>Type 2 possible"| H["BL, LL:<br/>ENL"] style E:::outcome style F:::decision style G:::outcome style H:::urgent ``` ### Clinical Features of Type 1 Reaction | Feature | Details | |---------|----------| | **Onset** | Can occur anytime during treatment or after completion | | **Skin Lesions** | **Inflammation of existing lesions** — become red, swollen, painful | | **Neuritis** | Painful, acute neuritis (often asymmetric) | | **Systemic** | Minimal systemic symptoms (unlike ENL) | | **Histology** | Epithelioid granulomas with increased cellularity | | **Mechanism** | Type IV hypersensitivity (cell-mediated) | ### Type 1 vs Type 2 Lepra Reactions — Complete Comparison | Feature | Type 1 (Reversal) | Type 2 (ENL) | |---------|-------------------|---------------| | **Hypersensitivity** | Type IV (delayed) | Type III (immune complex) | | **Leprosy Forms** | **BT, BB, BL only** | LL, BL | | **Timing** | Anytime (before, during, after Rx) | Usually first year of Rx | | **Lesion Change** | Existing lesions inflame | New painful nodules appear | | **Neuritis** | Acute, often asymmetric | Painful but symmetric | | **Systemic Sx** | Minimal | Fever, malaise, constitutional | | **Histology** | Epithelioid granulomas | Neutrophilic infiltrate | | **Frequency** | ~10–50% of borderline cases | ~50% of LL/BL cases | ### Why Option 2 is Incorrect **TT (Tuberculoid) and LL (Lepromatous) are STABLE polar forms** and do NOT undergo Type 1 lepra reactions. Only the **unstable borderline forms** (BT, BB, BL) are susceptible to reversal reactions. The option incorrectly includes TT, which is a stable polar form. **Clinical Pearl:** A helpful mnemonic: "**Borderline = Unstable = Reversal**" — only borderline forms can reverse. Polar forms (TT and LL) are immunologically stable and do not shift. **Warning:** Do NOT confuse the leprosy classification with reaction susceptibility. Just because a patient has leprosy does not mean they will have a reaction — reactions occur only in borderline forms (Type 1) or high-bacillary-load forms (Type 2).